Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United States
收藏Digital Science - Figshare2026-03-27 更新2026-03-28 收录
下载链接：
https://tandf.figshare.com/articles/journal_contribution/Cost-effectiveness_public_health_impact_and_budget_impact_of_receipt_of_Pfizer-BioNTech_COVID-19_vaccine_LP_8_1-adapted_2025_2026_formula_among_adults_aged_18_years_and_older_at_high_risk_for_severe_outcomes_from_COVID-19_in_the_United_Stat/31874255
下载链接
链接失效反馈官方服务：
资源简介：
Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United States
创建时间：
2026-03-27
